After all the Covid-19 ‘no-jab-no-job’ hoo-haa, NCDC workers withdraw case
News that matter in Papua New Guinea
Image for illustration only. For image info, go to https://asiapacificreport.nz/2021/09/04/no-jab-no-job-covid-policy-of-png-employers-stirs-constitutional-row/
After all the Covid-19 ‘no-jab-no-job’
hoo-haa, NCDC workers withdraw case
PORT MORESBY: After all the Coronavirus (Covid-19) hoo-haa,
National Capital District Commission (NCDC) employees have withdrawn their case
challenging the “no-jab-no-job” policy imposed by City Hall.
Deputy Chief Justice Ambeng
Kandakasi allowed the withdrawal of the case in Waigani yesterday when lawyer representing
the NCDC Workers Union George Kaore told the court that the situation had since
been relaxed and there were no more issues.
The news break was reported by The National:
NCDC workers
discontinue case
July 14, 2022The
NationalNational
By CLARISSA MOI
A case filed by
employees of the National Capital District Commission (NCDC) challenging the
legality of the ‘no-jab-no-job’ policy imposed by City Hall has been discontinued
by the National Court.
Deputy Chief Justice Ambeng Kandakasi made the ruling at Waigani yesterday when
lawyer representing the NCDC Workers Union George Kaore told the court that the
situation had since been relaxed and there were no more issues.
On Oct 12, last year, an inter-office memorandum titled “No jab, no job –
vaccinate by Oct 28, 2021” was signed by city manager Bernard Kipit.
This is regarding the Coronavirus (Covid-19) vaccination in which the NCDC
management required all employees to be vaccinated by Nov 1, or be taken off
the payroll.
Aggrieved by this notice, the NCDC Workers Union then took the matter to court.
Kipit, NCD Governor Powes Parkop and the NCDC were named as defendants.
When the matter came to court in November, Kaore said the NCDC employees asked
the court to enforce the rights of the workers pursuant to section 41 of the
Constitution (Prescribed Acts) and section 48 of the Constitution (Freedom of
employment).
He argued against Covid-19 vaccination being mandatory in the workplace.
Yesterday when the matter returned to court, Kandakasi asked Kaore if there
were any issue for this matter to proceed to trial.
Kaore responded that there were no more issues except that his clients’ rights
was still a concern.
“If there is no issue then withdraw the matter,” Kandakasi advised.
Lawyer representing the defendants Celestine Malala said that the NCDC Workers
Union had not taken steps to reach a settlement, as ordered by the court on May
5.
She said one of the orders was that if the plaintiff in the proceeding failed
to meaningfully participate in the settlement negotiations.
Govt approves another
three Covid-19 test kits
July 14, 2022The
NationalNational
THE Government has approved another three
Coronavirus (Covid-19) antigen rapid test kits for use in Papua New Guinea
(PNG).
National Pandemic Deputy Controller Dr Daoni Esorom said the three kits were
Singclean Antigen RDT, Lookspot Antigen RDT and Flow Flex Antigen.
“These kits are particularly for the severe acute respiratory syndrome (SARS)
CoV-2 screening and diagnosis.
“Quality diagnosis of diseases is crucial as it ensures appropriate clinical
intervention is administered but equally crucial is having the testing kit that
is validated for use in PNG,” he said.
“This ensures the diagnosis is reflective of the true status of the patient.
Validation was undertaken by the Central Public Health Laboratory last year.
“The new kits are in addition to BioPen Antigen RDT Kits that was initially
approved by the National Control Centre (NCC) for Covid-19 testing in the
country in 2020.
“We now have four approved Covid-19 test kits in the country.
These are the only approved kits approved for Covid-19 testing.
He said the Singclean antigen test kit (Colloidal Gold) manufactured by
Hangzhhou Singclean Medical Products Co Ltd was a solid phase
immunochromatographic assay for the rapid, qualitative detection of antigen of
Covid-19 in human saliva.
“Lookspot Antigen RDT test detects the nucleocapsid protein from SARS-CoV-2 in
nasal swabs from suspected Covid-19 patients in the first eight days of the
symptom.
“It delivers results in five to eight minutes.
“This rapid test kit is a smartphone-based diagnostic device with a lateral
flow immunoassay developed from Laipac, an internet medical developer.”
Comments
Post a Comment